INOGEN, INC.

INGN ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Revenue $249.4M $202.8M $159.0M $112.5M $75.4M $48.6M
Cost of Revenue $128.2M $105.5M $82.7M $57.0M $36.5M $24.6M
Gross Profit $121.2M $97.3M $76.3M $55.5M $39.0M $23.9M
Gross Margin 48.6% 48.0% 48.0% 49.3% 51.7% 49.3%
Operating Expenses
Research & Development $5.3M $5.1M $4.2M $3.0M $2.4M $2.3M
SG&A Expense $37.6M $31.8M $25.7M $17.9M $13.8M $8.3M
Operating Income $27.6M $22.9M $15.1M $10.5M $4.5M $829.0K
Operating Margin 11.1% 11.3% 9.5% 9.3% 5.9% 1.7%
Interest Expense $6.0K $22.0K $449.0K $562.0K $493.0K
Pretax Income $29.7M $22.7M $14.7M $10.1M $3.8M $582.0K
Income Tax Expense $8.7M $2.2M $3.1M $3.2M $-21.6M $18.0K
Net Income $21.0M $20.5M $11.6M $6.8M $25.4M $564.0K
Net Margin 8.4% 10.1% 7.3% 6.1% 33.7% 1.2%
EPS (Basic) $1.02 $1.02 $0.60 $0.33 $0.08 $-0.28
EPS (Diluted) $0.96 $0.97 $0.56 $0.30 $0.08 $-0.28
Shares Outstanding (Basic) 20.7M 20.1M 19.4M 16.2M 2.5M 18.8M
Shares Outstanding (Diluted) 21.9M 21.1M 20.7M 18.0M 18.1M 18.8M
Dividends Per Share
← Newer Page 2 of 2 Older →